Suppr超能文献

作为一种有前途的肝肾功能并发症相关 2 型糖尿病(体内和基于计算机的研究)辅助治疗药物。

Extract as a Promising Supplemental Agent for Hepatic and Renal Complication-Associated Type 2 Diabetes (In Vivo and In Silico-Based Studies).

机构信息

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences at Al-Qurayyat, Jouf University, Al-Qurayyat 77454, Saudi Arabia.

Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University, Jeddah 23761, Saudi Arabia.

出版信息

Int J Mol Sci. 2023 Sep 6;24(18):13759. doi: 10.3390/ijms241813759.

Abstract

Type 2 diabetes (T2D) is a chronic metabolic condition associated with obesity, oxidative stress-mediated inflammation, apoptosis, and impaired insulin signaling. The utilization of phytochemical therapy generated from plants has emerged as a promising approach for the treatment of diabetes and its complications. Kiwifruit is recognized for its substantial content of antioxidative phenolics. Therefore, this work aimed to examine the effect of (kiwi fruit) on hepatorenal damage in a high-fat diet (HFD) and streptozotocin (STZ)-induced T2D in rats using in vivo and in silico analyses. An increase in hepatic and renal lipid peroxidation was observed in diabetic rats accompanied by a decrease in antioxidant status. Furthermore, it is important to highlight that there were observable inflammatory and apoptotic responses in the hepatic and renal organs of rats with diabetes, along with a dysregulation of the phosphorylation levels of mammalian target of rapamycin (mTOR), protein kinase B (Akt), and phosphoinositide 3-kinase (PI3K) signaling proteins. However, the administration of kiwi extract to diabetic rats alleviated hepatorenal dysfunction, inflammatory processes, oxidative injury, and apoptotic events with activation of the insulin signaling pathway. Furthermore, molecular docking and dynamic simulation studies revealed quercetin, chlorogenic acid, and melezitose as components of kiwi extract that docked well with potential as effective natural products for activating the silent information regulator 1(SIRT-1) pathway. Furthermore, phenolic acids in kiwi extract, especially syringic acid, P-coumaric acid, caffeic acid, and ferulic acid, have the ability to inhibit the phosphatase and tensin homolog (PTEN) active site. In conclusion, it can be argued that kiwi extract may present a potentially beneficial adjunctive therapy approach for the treatment of diabetic hepatorenal complications.

摘要

2 型糖尿病(T2D)是一种与肥胖、氧化应激介导的炎症、细胞凋亡和胰岛素信号受损相关的慢性代谢性疾病。利用植物来源的植物化学疗法已成为治疗糖尿病及其并发症的一种有前途的方法。猕猴桃因其含有大量抗氧化酚类物质而受到关注。因此,本工作旨在通过体内和体外分析研究猕猴桃(kiwi fruit)对高脂肪饮食(HFD)和链脲佐菌素(STZ)诱导的 T2D 大鼠肝肾功能损伤的影响。糖尿病大鼠肝肾功能损伤的模型中,肝肾功能损伤伴随着抗氧化状态的下降,导致肝肾功能损伤,肝肾功能损伤伴随着炎症和凋亡反应。此外,糖尿病大鼠肝肾功能损伤的模型中,哺乳动物雷帕霉素靶蛋白(mTOR)、蛋白激酶 B(Akt)和磷酸肌醇 3-激酶(PI3K)信号通路蛋白的磷酸化水平也出现了失调。然而,猕猴桃提取物的给药可以减轻糖尿病大鼠的肝肾功能障碍、炎症过程、氧化损伤和凋亡事件,并激活胰岛素信号通路。此外,分子对接和动态模拟研究表明,猕猴桃提取物中的槲皮素、绿原酸和密二糖等成分与沉默信息调节因子 1(SIRT-1)通路的有效天然产物结合良好。此外,猕猴桃提取物中的酚酸,特别是丁香酸、对香豆酸、咖啡酸和阿魏酸,具有抑制磷酸酶和张力蛋白同源物(PTEN)活性位点的能力。综上所述,猕猴桃提取物可能为治疗糖尿病肝肾功能并发症提供一种潜在的辅助治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e519/10530616/c3391917b55d/ijms-24-13759-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验